Covered recipient · General Payments record
JULIE U VU
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$415.45
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $415.45 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $63.63 | 3 |
| Merck Sharp & Dohme Corporation | $61.29 | 2 |
| Lilly USA, LLC | $56.20 | 2 |
| Novo Nordisk AS | $53.65 | 3 |
| Amgen Inc. | $53.60 | 2 |
| PFIZER INC. | $38.41 | 2 |
| Insmed, Inc. | $33.20 | 1 |
| Mylan Specialty L.P. | $28.92 | 1 |
| GlaxoSmithKline, LLC. | $26.55 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $415.45 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $25.32 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711264 | CMS |
| Amgen Inc. | $28.28 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711266 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.03 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104703229 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.21 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105576646 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.39 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104527390 | CMS |
| GlaxoSmithKline, LLC. | $26.55 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116360568 | CMS |
| Insmed, Inc. | $33.20 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089571734 | CMS |
| Lilly USA, LLC | $26.19 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135719876 | CMS |
| Lilly USA, LLC | $30.01 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135719878 | CMS |
| Merck Sharp & Dohme LLC | $30.92 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141727552 | CMS |
| Merck Sharp & Dohme LLC | $30.37 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141727554 | CMS |
| Mylan Specialty L.P. | $28.92 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147368871 | CMS |
| Novo Nordisk Inc | $22.43 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100556845 | CMS |
| Novo Nordisk Inc | $14.01 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100641348 | CMS |
| Novo Nordisk Inc | $17.21 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100314557 | CMS |
| PFIZER INC. | $18.41 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131547084 | CMS |
| PFIZER INC. | $20.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131506003 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.